Epigenos Biosciences
Epigenos Biosciences develops personalized epigenome-based therapeutics that leverage Cas9 technology to treat disease at the root of gene mis-regulation.
Alert Banner
Alert:Watch the Boston Globe Today’s video on why North Carolina is an attractive place to grow a life sciences business, including lower business costs and highly skilled workforce.
Close Search Window
